Junkes L, Gherman B, Appolinario J, Nardi A
PLoS One. 2024; 19(5):e0303967.
PMID: 38776336
PMC: 11111054.
DOI: 10.1371/journal.pone.0303967.
Arjmand S, Grassi-Oliveira R, Wegener G
Eur Psychiatry. 2023; 66(1):e14.
PMID: 36632817
PMC: 9970145.
DOI: 10.1192/j.eurpsy.2022.2353.
Adekkanattu P, Olfson M, Susser L, Patra B, Vekaria V, Coombes B
J Affect Disord. 2022; 324:102-113.
PMID: 36529406
PMC: 10327872.
DOI: 10.1016/j.jad.2022.12.044.
Nunez N, Joseph B, Pahwa M, Kumar R, Resendez M, Prokop L
J Affect Disord. 2022; 302:385-400.
PMID: 34986373
PMC: 9328668.
DOI: 10.1016/j.jad.2021.12.134.
Liu L, Golts M, Fernandes V
Pharmacy (Basel). 2021; 9(3).
PMID: 34202267
PMC: 8293424.
DOI: 10.3390/pharmacy9030118.
Refractory Gilles de la Tourette Syndrome-Many Pieces That Define the Puzzle.
Szejko N, Lombroso A, Bloch M, Landeros-Weisenberger A, Leckman J
Front Neurol. 2021; 11:589511.
PMID: 33391155
PMC: 7775596.
DOI: 10.3389/fneur.2020.589511.
Recent Updates on Electro-Convulsive Therapy in Patients with Depression.
Park M, Kim H, Kim E, Yook V, Chung I, Lee S
Psychiatry Investig. 2020; 18(1):1-10.
PMID: 33321557
PMC: 7897863.
DOI: 10.30773/pi.2020.0350.
Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases.
Fornaro M, Fusco A, Novello S, Mosca P, Anastasia A, De Blasio A
Front Psychiatry. 2020; 11:438.
PMID: 32670098
PMC: 7326075.
DOI: 10.3389/fpsyt.2020.00438.
Effects of Exercise on Long-Term Potentiation in Neuropsychiatric Disorders.
Loprinzi P
Adv Exp Med Biol. 2020; 1228:439-451.
PMID: 32342476
DOI: 10.1007/978-981-15-1792-1_30.
Management of Treatment-Resistant Depression: Challenges and Strategies.
Voineskos D, Daskalakis Z, Blumberger D
Neuropsychiatr Dis Treat. 2020; 16:221-234.
PMID: 32021216
PMC: 6982454.
DOI: 10.2147/NDT.S198774.
The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial.
Zeifman R, Palhano-Fontes F, Hallak J, Arcoverde E, Maia-Oliveira J, Araujo D
Front Pharmacol. 2019; 10:1325.
PMID: 31798447
PMC: 6878725.
DOI: 10.3389/fphar.2019.01325.
Significant Decrease in Hippocampus and Amygdala Mean Diffusivity in Treatment-Resistant Depression Patients Who Respond to Electroconvulsive Therapy.
Yrondi A, Nemmi F, Billoux S, Giron A, Sporer M, Taib S
Front Psychiatry. 2019; 10:694.
PMID: 31607967
PMC: 6761799.
DOI: 10.3389/fpsyt.2019.00694.
Implementation of intermittent theta burst stimulation compared to conventional repetitive transcranial magnetic stimulation in patients with treatment resistant depression: A cost analysis.
Mendlowitz A, Shanbour A, Downar J, Vila-Rodriguez F, Daskalakis Z, Isaranuwatchai W
PLoS One. 2019; 14(9):e0222546.
PMID: 31513675
PMC: 6742475.
DOI: 10.1371/journal.pone.0222546.
Epidemiology of pharmaceutically treated depression and treatment resistant depression in South Korea.
Kim N, Cho S, Kim H, Kim S, Lee H, Park C
PLoS One. 2019; 14(8):e0221552.
PMID: 31442296
PMC: 6707549.
DOI: 10.1371/journal.pone.0221552.
Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study).
Yrondi A, Aouizerate B, El-Hage W, Moliere F, Thalamas C, Delcourt N
Front Psychiatry. 2018; 9:326.
PMID: 30087626
PMC: 6066663.
DOI: 10.3389/fpsyt.2018.00326.
Standardisation framework for the Maudsley staging method for treatment resistance in depression.
Fekadu A, Donocik J, Cleare A
BMC Psychiatry. 2018; 18(1):100.
PMID: 29642877
PMC: 5896127.
DOI: 10.1186/s12888-018-1679-x.
Significant Need for a French Network of Expert Centers Enabling a Better Characterization and Management of Treatment-Resistant Depression (Fondation FondaMental).
Yrondi A, Bennabi D, Haffen E, Garnier M, Bellivier F, Bourgerol T
Front Psychiatry. 2017; 8:244.
PMID: 29225582
PMC: 5706526.
DOI: 10.3389/fpsyt.2017.00244.
A Review of the Conceptualisation and Risk Factors Associated with Treatment-Resistant Depression.
Murphy J, Sarris J, Byrne G
Depress Res Treat. 2017; 2017:4176825.
PMID: 28840042
PMC: 5559917.
DOI: 10.1155/2017/4176825.
Treatment-resistant depression in primary care across Canada.
Rizvi S, Grima E, Tan M, Rotzinger S, Lin P, McIntyre R
Can J Psychiatry. 2014; 59(7):349-57.
PMID: 25007419
PMC: 4086317.
DOI: 10.1177/070674371405900702.
Facebook enhances antidepressant pharmacotherapy effects.
Mota Pereira J
ScientificWorldJournal. 2014; 2014:892048.
PMID: 24574930
PMC: 3916106.
DOI: 10.1155/2014/892048.